Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0000902664-21-001835

Director sold 806,000 shares at an average $39.99 ($32,228,827)

From the SEC's structured data for this filing

Trades in this filing

GOEL DAVID E. · Director

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-08 Sale : show line 1 in the form −234,295 $38.22 $8,954,310 12,880,795 I
2021-03-08 Sale : show line 2 in the form −75,000 $39.22 $2,941,163 12,805,795 I
2021-03-08 Sale : show line 3 in the form −33,600 $39.97 $1,343,039 12,772,195 I
2021-03-08 Sale : show line 4 in the form −71,194 $41.21 $2,933,641 12,701,001 I
2021-03-08 Sale : show line 5 in the form −85,911 $41.62 $3,575,753 12,615,090 I
2021-03-09 Sale : show line 6 in the form −215,698 $40.42 $8,719,333 12,399,392 I
2021-03-09 Sale : show line 7 in the form −34,302 $41.16 $1,411,887 12,365,090 I
2021-03-10 Sale : show line 8 in the form −25,732 $41.47 $1,067,037 12,339,358 I
2021-03-10 Sale : show line 9 in the form −30,268 $42.38 $1,282,664 12,309,090 I
Open-market sales · 806,000 sh · avg $39.99 · $32,228,827
Loading xslF345X03/ownership.xml…